Fundraising Fox

Dare Bioscience

NASDAQ: DARE

San Diego, US · Delaware corporation · 1 known investors

Biotech

Founders & leadership

MH
MarDee Haring-LaytonChief Accounting Officer
SM
Sabrina Martucci JohnsonPresident and Chief Executive Officer
CD
Christopher D.T. GuiffreExecutive Officer, Director
GB
Gregg BeloffExecutive Officer
AV
Alejandra V. CarvajalExecutive Officer
AS
Adrian SenderowiczExecutive Officer
DR
David R. ParkinsonDirector
WT
William T. McKeeDirector
AL
Alan L. CraneDirector
DW
David WaltDirector
SA
Stuart A. ArbuckleDirector
PA
Paul A. FriedmanDirector

Investors · 1

Reported raises · per SEC filings

Form D private placements
$15MofferedNov 2024 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • MarDee Haring-LaytonExecutive Officer
  • Jessica GrossmanDirector
  • William H. RastetterDirector
  • Robin SteeleDirector
  • Susan L. KelleyDirector
  • Sabrina Martucci JohnsonExecutive Officer, Director
  • Gregory W. MatzDirector
Offering amount
$15M
First sale
Oct 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$1.7MraisedDec 2023 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Sophia N. Ononye-OnyiaDirector
  • Jessica D. GrossmanDirector
  • Cheryl R. BlanchardDirector
  • Susan L. KelleyDirector
  • Robin J. SteeleDirector
  • Lisa Walters-HoffertExecutive Officer
  • William H. RastetterDirector
  • Sabrina Martucci JohnsonExecutive Officer, Director
  • Gregory W. MatzDirector
Offering amount
$4.2M
Amount sold
$1.7M
First sale
Dec 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$3.5MraisedSep 2021 · 28 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Robin J. SteeleDirector
  • Susan L. KelleyDirector
  • Lisa Walters-HoffertExecutive Officer
  • Jessica D. GrossmanDirector
  • Cheryl BlanchardDirector
  • William H. RastetterDirector
  • Gregory W. MatzDirector
  • Sabrina Martucci JohnsonExecutive Officer, Director
Offering amount
$3.5M
Amount sold
$3.5M
First sale
Nov 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$20.7MraisedJul 2017 · 18 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Robin J. SteeleDirector
  • Lisa Walters-HoffertExecutive Officer
  • Roger L. HawleyDirector
  • William H. RastetterDirector
  • Susan L. KelleyDirector
  • Sabrina Martucci JohnsonExecutive Officer, Director
Offering amount
$20.7M
Amount sold
$20.7M
First sale
Jul 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$1raisedOct 2016 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Christopher D.T. GuiffreExecutive Officer, Director
  • Gregg BeloffExecutive Officer
  • Alejandra V. CarvajalExecutive Officer
  • Adrian SenderowiczExecutive Officer
  • David R. ParkinsonDirector
  • William H. RastetterDirector
  • William T. McKeeDirector
  • Alan L. CraneDirector
  • Susan L. KelleyDirector
  • David WaltDirector
  • Stuart A. ArbuckleDirector
  • Paul A. FriedmanDirector
Offering amount
$1
Amount sold
$1
First sale
Oct 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.